BUY G R Infraprojects Ltd. — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)12 Nov 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
The Madhya Pradesh High Court has quashed a GST show cause notice previously issued to the company by the Office of the Joint Commissioner of State Tax.
NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·16 Oct · 6d ago
G R Infraprojects has executed a concession agreement for a project.
BSE · Company Update·15 Oct · 1w ago
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·13 May · 5mo ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·22 Oct · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on G R Infraprojects
- BUY — Axis Securities13 May 2026 · ~1 year · target ₹1,130 · Active
- BUY — Axis Securities18 Apr 2026 · ~1 year · target ₹996 · Target hit
- BUY — Motilal Oswal10 Feb 2026 · ~1 year · target ₹1,250 · Active
- BUY — Axis Securities12 Nov 2025 · ~1 year · target ₹1,420 · Active
- BUY — Motilal Oswal11 Nov 2025 · ~1 year · target ₹1,360 · Active
More from ICICI Securities
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹969 · Active
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active

